Vaxchora (Cholera Vaccine, Live, Oral) is a?vaccine indicated for active immunization against disease caused?by Vibrio cholera serogroup O1.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Cholera Vaccine (Oral Route) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Shanchol
Dukoral
Vaxchora
Others
Market Segment by Product Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Finally, the report provides detailed profile and data information analysis of leading company.
PaxVax
Sanofi
Valneva
EuBiologics
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Cholera Vaccine (Oral Route) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Cholera Vaccine (Oral Route) market by identifying its various subsegments.
3.Focuses on the key global Cholera Vaccine (Oral Route) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cholera Vaccine (Oral Route) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cholera Vaccine (Oral Route) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Cholera Vaccine (Oral Route) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Cholera Vaccine (Oral Route) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Cholera Vaccine (Oral Route) Segment by Type
2.1.1 Shanchol
2.1.2 Dukoral
2.1.3 Vaxchora
2.1.4 Others
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Research & Academic Laboratories
2.2.3 Pharmaceutical & Biotechnology Companies
2.2.4 Others
2.3 Global Cholera Vaccine (Oral Route) Market Comparison by Regions (2017-2027)
2.3.1 Global Cholera Vaccine (Oral Route) Market Size (2017-2027)
2.3.2 North America Cholera Vaccine (Oral Route) Status and Prospect (2017-2027)
2.3.3 Europe Cholera Vaccine (Oral Route) Status and Prospect (2017-2027)
2.3.4 China Cholera Vaccine (Oral Route) Status and Prospect (2017-2027)
2.3.5 Japan Cholera Vaccine (Oral Route) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Cholera Vaccine (Oral Route) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Cholera Vaccine (Oral Route) Industry Impact
2.5.1 Cholera Vaccine (Oral Route) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Cholera Vaccine (Oral Route) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Cholera Vaccine (Oral Route) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Cholera Vaccine (Oral Route) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Cholera Vaccine (Oral Route) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Cholera Vaccine (Oral Route) Manufacturer Market Share
3.5 Top 10 Cholera Vaccine (Oral Route) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
3.7 Key Manufacturers Cholera Vaccine (Oral Route) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Cholera Vaccine (Oral Route) Industry Key Manufacturers
4.1 PaxVax
4.1.1 Compan Detail
4.1.2 PaxVax Cholera Vaccine (Oral Route) Product Introduction, Application and Specification
4.1.3 PaxVax 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 PaxVax News
4.2 Sanofi
4.2.1 Compan Detail
4.2.2 Sanofi Cholera Vaccine (Oral Route) Product Introduction, Application and Specification
4.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 PaxVax News
4.3 Valneva
4.3.1 Compan Detail
4.3.2 Valneva Cholera Vaccine (Oral Route) Product Introduction, Application and Specification
4.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Valneva News
4.4 EuBiologics
4.4.1 Compan Detail
4.4.2 EuBiologics Cholera Vaccine (Oral Route) Product Introduction, Application and Specification
4.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 EuBiologics News
5 Global Cholera Vaccine (Oral Route) Market Segment by Big Type
5.1 Global Cholera Vaccine (Oral Route) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Cholera Vaccine (Oral Route) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Cholera Vaccine (Oral Route) Revenue and Market Share by Big Type (2017-2022)
5.2 Shanchol Sales Growth Rate and Price
5.2.1 Global Shanchol Sales Growth Rate (2017-2022)
5.2.2 Global Shanchol Price (2017-2022)
5.3 Dukoral Sales Growth Rate and Price
5.3.1 Global Dukoral Sales Growth Rate (2017-2022)
5.3.2 Global Dukoral Price (2017-2022)
5.4 Vaxchora Sales Growth Rate and Price
5.4.1 Global Vaxchora Sales Growth Rate (2017-2022)
5.4.2 Global Vaxchora Price (2017-2022)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2017-2022)
5.5.2 Global Others Price (2017-2022)
6 Global Cholera Vaccine (Oral Route) Market Segment by Big Application
6.1 Global Cholera Vaccine (Oral Route) Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Research & Academic Laboratories Sales Growth Rate (2017-2022)
6.4 Pharmaceutical & Biotechnology Companies Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Cholera Vaccine (Oral Route) Forecast
7.1 Global Cholera Vaccine (Oral Route) Revenue, Sales and Growth Rate (2022-2027)
7.2 Cholera Vaccine (Oral Route) Market Forecast by Regions (2022-2027)
7.2.1 North America Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.2.2 Europe Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.2.3 China Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.2.4 Japan Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.2.5 Southeast Asia Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.2.6 Other Regions Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
7.3 Cholera Vaccine (Oral Route) Market Forecast by Type (2022-2027)
7.3.1 Global Cholera Vaccine (Oral Route) Sales Forecast by Type (2022-2027)
7.3.2 Global Cholera Vaccine (Oral Route) Market Share Forecast by Type (2022-2027)
7.4 Cholera Vaccine (Oral Route) Market Forecast by Application (2022-2027)
7.4.1 Global Cholera Vaccine (Oral Route) Sales Forecast by Application (2022-2027)
7.4.2 Global Cholera Vaccine (Oral Route) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Cholera Vaccine (Oral Route) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Cholera Vaccine (Oral Route) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Cholera Vaccine (Oral Route)
Figure Market Concentration Ratio and Market Maturity Analysis of Cholera Vaccine (Oral Route)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Cholera Vaccine (Oral Route) Market Size by Big Type
Figure Global Market Share of Cholera Vaccine (Oral Route) by Big Type in 2021
Figure Shanchol Picture (2017-2022)
Figure Dukoral Picture (2017-2022)
Figure Vaxchora Picture (2017-2022)
Global Cholera Vaccine (Oral Route) Market Size by Big Application
Table Global Cholera Vaccine (Oral Route) Market Size by Application
Figure Global Cholera Vaccine (Oral Route) Market Share by Big Application in 2021
Figure Hospital Picture
Figure Research & Academic Laboratories Picture
Figure Pharmaceutical & Biotechnology Companies Picture
Figure Others Picture
Table Global Cholera Vaccine (Oral Route) Comparison by Regions (M USD) (2017-2027)
Figure Global Cholera Vaccine (Oral Route) Market Size (Million US$) (2017-2027)
Figure North America Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Cholera Vaccine (Oral Route) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Cholera Vaccine (Oral Route) Sales by Manufacturer (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturer in 2021
Table Global Cholera Vaccine (Oral Route) Revenue by Manufacturer (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturer in 2021
Table Global Cholera Vaccine (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
Table Key Manufacturers Cholera Vaccine (Oral Route) Product Type
Table Mergers & Acquisitions Planning
Table PaxVax Company Profile
Table Cholera Vaccine (Oral Route) Product Introduction, Application and Specification of PaxVax
Table Cholera Vaccine (Oral Route) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Sanofi Company Profile
Table Cholera Vaccine (Oral Route) Product Introduction, Application and Specification of Sanofi
Table Cholera Vaccine (Oral Route) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Recent Development
Table Valneva Company Profile
Table Cholera Vaccine (Oral Route) Product Introduction, Application and Specification of Valneva
Table Cholera Vaccine (Oral Route) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Valneva Main Business
Table Valneva Recent Development
Table EuBiologics Company Profile
Table Cholera Vaccine (Oral Route) Product Introduction, Application and Specification of EuBiologics
Table Cholera Vaccine (Oral Route) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table EuBiologics Main Business
Table EuBiologics Recent Development
Table EuBiologics Main Business
Table EuBiologics Recent Development
Figure Global Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2022)
Table Global Cholera Vaccine (Oral Route) Sales by Regions (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Sales Market Share by Regions in 2021
Table Global Cholera Vaccine (Oral Route) Revenue by Regions (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Revenue Market Share by Regions in 2021
Figure North America Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure Europe Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure China Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure Japan Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Figure Other Regions Cholera Vaccine (Oral Route) Sales and Growth Rate (2017-2022)
Table Global Cholera Vaccine (Oral Route) Sales by Big Type (2017-2022)
Table Global Cholera Vaccine (Oral Route) Sales Market Share by Big Type (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Sales Market Share by Big Type in 2019
Table Global Cholera Vaccine (Oral Route) Revenue by Big Type (2017-2022)
Table Global Cholera Vaccine (Oral Route) Revenue Market Share by Big Type (2017-2022)
Table Global Cholera Vaccine (Oral Route) Revenue Market Share by Big Type in 2019
Figure Global Shanchol Sales Growth Rate (2017-2022)
Figure Global Shanchol Price (2017-2022)
Figure Global Dukoral Sales Growth Rate (2017-2022)
Figure Global Dukoral Price (2017-2022)
Figure Global Vaxchora Sales Growth Rate (2017-2022)
Figure Global Vaxchora Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Cholera Vaccine (Oral Route) Sales by Big Application (2017-2022)
Table Global Cholera Vaccine (Oral Route) Sales Market Share by Big Application (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Research & Academic Laboratories Sales Growth Rate (2017-2022)
Figure Global Pharmaceutical & Biotechnology Companies Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Cholera Vaccine (Oral Route) Sales and Growth Rate (2022-2027)
Figure Global Cholera Vaccine (Oral Route) Revenue and Growth Rate (2022-2027)
Table Global Cholera Vaccine (Oral Route) Sales Forecast by Regions (2022-2027)
Table Global Cholera Vaccine (Oral Route) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Figure Europe Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Figure China Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Figure Japan Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Figure Southeast Asia Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Figure Other Regions Sales Cholera Vaccine (Oral Route) Market Forecast (2022-2027)
Table Global Cholera Vaccine (Oral Route) Sales Forecast by Type (2022-2027)
Table Global Cholera Vaccine (Oral Route) Market Share Forecast by Type (2022-2027)
Table Global Cholera Vaccine (Oral Route) Sales Forecast by Application (2022-2027)
Table Global Cholera Vaccine (Oral Route) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cholera Vaccine (Oral Route)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Cholera Vaccine (Oral Route) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Cholera Vaccine (Oral Route) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Cholera Vaccine (Oral Route) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Cholera Vaccine (Oral Route) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Cholera Vaccine (Oral Route) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
PaxVax
Sanofi